Challenging Near InfraRed Spectroscopy discriminating ability for counterfeit pharmaceuticals detection

Analytica Chimica Acta

Volumn 658, Issue 2, 2010, Pages 163-174

  Storme Paris, I ^a   Rebiere, H ^b   Matoga, M ^a   Civade, C ^b   Bonnet, P A ^b   Tissier, M H ^b   Chaminade, P ^a  

^a IPSIT   (France)

^b French Health Products Safety Agency (AFSSAPS)   (France)

Author keywords

Chemometrics; Counterfeits; Generics; Imitations; Near InfraRed Spectroscopy; Near InfraRed Spectroscopy discriminating ability; Specificity

Indexed keywords

ACTIVE PHARMACEUTICAL INGREDIENTS; CHEMOMETRICES; CHEMOMETRICS; CIPROFLOXACIN; COUNTERFEIT DRUGS; COUNTERFEITS; DATA CLASSIFICATION; EXPLORATORY ANALYSIS; FLUOXETINE; GENERIC DATABASE; GLOBAL THREATS; HEALTH PRODUCTS; HIGH-STRENGTH TABLETS; MANUFACTURING SITES; MEDICINAL PRODUCTS; OPTIMISATIONS; PRE-TREATMENTS; PUBLIC HEALTH; SPECTRAL DIFFERENCES; THEORETICAL LIMITS;

ANTIBIOTICS; CLUSTER ANALYSIS; DATA HANDLING; HEALTH RISKS; INDEPENDENT COMPONENT ANALYSIS; INFRARED DEVICES; INFRARED TRANSMISSION; NEAR INFRARED SPECTROSCOPY; PRINCIPAL COMPONENT ANALYSIS; SENSITIVITY ANALYSIS; SPECTRUM ANALYSIS; WATER ANALYSIS;

INFRARED SPECTROSCOPY;

CIPROFLOXACIN; EXCIPIENT; FLUOXETINE; GENERIC DRUG;

ALGORITHM; ARTICLE; CALIBRATION; CHEMOMETRICS; CLUSTER ANALYSIS; CONTROLLED STUDY; DRUG CAPSULE; DRUG COATING; DRUG DETERMINATION; DRUG DISCRIMINATION; DRUG FORMULATION; DRUG MANUFACTURE; DRUG MEGADOSE; DRUG SAFETY; DRUG SCREENING; EXPLORATORY RESEARCH; NEAR INFRARED SPECTROSCOPY; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; PROCESS OPTIMIZATION; SENSITIVITY ANALYSIS; TABLET FORMULATION;

ANTI-INFECTIVE AGENTS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CIPROFLOXACIN; DRUGS, GENERIC; FLUOXETINE; PRINCIPAL COMPONENT ANALYSIS; SPECTROSCOPY, NEAR-INFRARED; TABLETS;

EID: 72149125898     PISSN: 00032670     EISSN: 18734324     Source Type: Journal    
DOI: 10.1016/j.aca.2009.11.005     Document Type: Article

References (38)

1. Cockburn R., Newton P.N., Agyarko E.K., Akunyili D., and White N.J. PLoS Med. 2 (2005) e100
2. WHO, Counterfeit Medicines, Fact Sheet 275, 2006, http://www.who.int/mediacentre/factsheets/fs275/en/print.html.
3. Westenberger B.J., Ellison C.D., Fussner A.S., Jenney S., Kolinski R.E., Lipe T.G., Lyon R.C., Moore T.W., Revelle L.K., Smith A.P., Spencer J.A., Story K.D., Toler D.Y., Wokovich A.M., and Buhse L.F. Int. J. Pharm. 306 (2005) 56-70
4. European Commission, 2007, http://ec.europa.eu/taxation_customs/customs/customs_controls/counterfei t_piracy/statistics/index_en.htm
5. Burns W. Bull. World Health Organ. 84 (2006) 689-690
6. Rebiere H., Mazel B., Civade C., and Bonnet P.A. J. Chromatogr. B 850 (2007) 376-383
7. Schad G.J., Allanson A., Mackay S.P., Cannavan A., and Tettey J.N. J. Pharm. Biomed. Anal. 46 (2008) 45-51
8. Panusa A., Multari G., Incarnato G., and Gagliardi L. J. Pharm. Biomed. Anal. 43 (2007) 1221-1227
9. Trefi S., Routaboul C., Hamieh S., Gilard V., Malet-Martino M., and Martino R. J. Pharm. Biomed. Anal. 47 (2008) 103-113
10. de Veij M., Deneckere A., Vandenabeele P., de Kaste D., and Moens L. J. Pharm. Biomed. Anal. 46 (2008) 303-309
11. Maurin J.K., Plucinski F., Mazurek A.P., and Fijalek Z. J. Pharm. Biomed. Anal. 43 (2007) 1514-1518
12. Green M.D., Nettey H., Villalva Rojas O., Pamanivong C., Khounsaknalath L., Grande Ortiz M., Newton P.N., Fernandez F.M., Vongsack L., and Manolin O. J. Pharm. Biomed. Anal. 43 (2007) 105-110
13. Rodionova O.Y., Houmoller L.P., Pomerantsev A.L., Geladi P., Burger J., Dorofeyev V.L., and Arzamastev A.P. Anal. Chim. Acta 549 (2005) 151-158
14. de Peinder P., Vredenbregt M.J., Visser T., and de Kaste D. J. Pharm. Biomed. Anal. 47 (2008) 688-694
15. O'Neil A.J., Jee R.D., Lee G., Charvill A., and Moffat A.C. J. Near Infrared Spectrosc. 16 (2008) 327-333
16. Vredenbregt M.J., Blok-Tip L., Hoogerbrugge R., Barends D.M., and de Kaste D. J. Pharm. Biomed. Anal. 40 (2006) 840-849
17. Olsen B.A., Borer M.W., Perry F.M., and Forbes R.A. Pharm. Technol. 26 6 (2002) 62-95
18. Scafi S.H., and Pasquini C. Analyst 126 (2001) 2218-2224
19. Candolfi A., De Maesschalck R., Jouan-Rimbaud D., Hailey P.A., and Massart D.L. J. Pharm. Biomed. Anal. L21 (1999) 115-132
20. Barnes R.J., Dhanoa M.S., and Lister S.J. Appl. Spectrosc. 43 (1989) 772-777
21. Vredenbregt M., Caspers P., Hoogerbrugge R., and Barends D. Eur. J. Pharm. Biopharm. 56 (2003) 489-499
22. Gemperline P., and Boyer N. Anal. Chem. 67 (1995) 160-166
23. Eriksson L., Johansson E., Kettaneh-Wold N., Trygg J., Wikström C., and Wold S. Classification and discrimination, multi- and megavariate data analysis. Part I. Basic principles and applications. Umetrics Academy (2006) 171-194
24. Wu W., Mallet Y., Walczak B., Penninckx W., Massart D.L., Heuerding S., and Erni F. Anal. Chim. Acta 329 (1996) 257-265
25. Laloum E. Méthode Nircal cluster appliquée à l'identification de produits par spectroscopie proche infrarouge (2004). http://nte-serveur.univ-lyon1.fr/spectroscopie/Nouveau%20dossier/posterl aloum.pdf
26. Ulmschneider M., and Penigault E. Analusis 28 (2000) 136-140
27. Derde M., Buydens L., Guns C., and Massart D.L. Anal. Chem. 59 (1987) 1868-1871
28. Wu T., Huang S., and Meng Y. Expert Syst. Appl. 34 (2008) 1846-1856
29. P. Caspers, M. Vredenbregt, R. Hoogerbrugge, D. Van Riet-Nales, D. Barends, RIVM Report 670400003, 2002, http://rivm.openrepository.com/rivm/bitstream/10029/19281/10021/67040000 3.pdf.
30. Reich G. Adv. Drug Deliv. Rev. 57 (2005) 1109-1143
31. Yoon W.L., Jee R.D., and Moffat A.C. Analyst 123 (1998) 1029-1034
32. Yoon W.L., Jee R.D., Charvill A., Lee G., and Moffat A.C. J. Pharm. Biomed. Anal. 34 (2004) 933-944
33. Roggo Y., Roeseler C., and Ulmschneider M. J. Pharm. Biomed. Anal. 36 (2004) 777-786
34. Roggo Y., Jent N., Edmond A., Chalus P., and Ulmschneider M. Eur. J. Pharm. Biopharm. 61 (2005) 100-110
35. Paris I., Janoly-Dumenil A., Paci A., Mercier L., Bourget P., Brion F., Chaminade P., and Rieutord A. J. Pharm. Biomed. Anal. 41 (2006) 1171-1178
36. Hubert P., Nguyen-Huu J.J., Boulanger B., Chapuzet E., Chiap P., Cohen N., Compagnon P.A., Dewe W., Feinberg M., Lallier M., Laurentie M., Mercier N., Muzard G., Nivet C., and Valat L. J. Pharm. Biomed. Anal. 36 (2004) 579-586
37. Hubert P., Nguyen-Huu J.J., Boulanger B., Chapuzet E., Chiap P., Cohen N., Compagnon P.A., Dewe W., Feinberg M., Lallier M., Laurentie M., Mercier N., Muzard G., Nivet C., Valat L., and Rozet E. J. Pharm. Biomed. Anal. 45 (2007) 70-81
38. Hubert P., Nguyen-Huu J.J., Boulanger B., Chapuzet E., Cohen N., Compagnon P.A., Dewe W., Feinberg M., Laurentie M., Mercier N., Muzard G., Valat L., and Rozet E. J. Pharm. Biomed. Anal. 45 (2007) 82-96